Study of AlloGen® Liquid Intra-articular Injection for Knee Osteoarthritis

Summary

A randomized, double-blind, placebo-controlled trial comparing a single intra-articular injection of 2.0 mL AlloGen vs 2.0 mL sterile saline. Patients will be evaluated at baseline, 1 week, 6 weeks, 12 weeks, and 26 weeks.

Timeline

Start

2021-06-01

Primary completion

2022-03-01

Completion

2022-06-30

Outcome

Outcome not reported

Stopped: “Company decision”

Drugs

Indications